Universal CAR-T Cell Therapy for NHL

This is a single-center, single-arm, open-label clinical study, and the sample size is set to 3-6 subjects.

NCT Number	NCT07248163
Lead Sponsor	Bioray Laboratories Collaborators: Shanghai Tongji Hospital, Tongji University School of Medicine
Conditions	Non-hodgkin Lymphoma,B Cell
Enrollment	6 participants
Start Date	2025-03-11
Primary Completion	2027-08-15 (estimated)
Study Completion	2028-03-11 (estimated)
Updated on ClinicalTrials.gov	2025-11-25